SILUMBRA suvorexant 20mg tablet blister pack

Quốc gia: Úc

Ngôn ngữ: Tiếng Anh

Nguồn: Department of Health (Therapeutic Goods Administration)

Thành phần hoạt chất:

suvorexant, Quantity: 20 mg

Sẵn có từ:

Merck Sharp & Dohme (Australia) Pty Ltd

INN (Tên quốc tế):

suvorexant

Dạng dược phẩm:

Tablet, film coated

Thành phần:

Excipient Ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; copovidone; croscarmellose sodium; titanium dioxide; hypromellose; triacetin

Tuyến hành chính:

Oral

Các đơn vị trong gói:

30 tablets, 3 tablets, 10 tablets

Loại thuốc theo toa:

(S4) Prescription Only Medicine

Chỉ dẫn điều trị:

SILUMBRA is indicated for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance. Following initiation of treatment, continuation should be re-evaluated after 3 months [see Pharmacodynamic Properties, Clinical trials and Adverse Effects (Undesirable Effects) for clinical trial durations].

Tóm tắt sản phẩm:

Visual Identification: White, round, biconvex, film coated tablet, marked with MSD logo and 335 on one side, and plain on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Tình trạng ủy quyền:

Registered

Ngày ủy quyền:

2016-11-16